Glboal Visceral Pain Therapeutics Pipeline Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Visceral Pain - Pipeline Review, H2 2016" report to their offering.

'Visceral Pain - Pipeline Review, H2 2016'; Visceral Pain pipeline therapeutics constitutes close to 16 molecules. Out of which approximately 11 molecules are developed by Companies and remaining by the Universities Institutes.

Furthermore, the publisher says; Visceral Pain Visceral pain is a type of nociceptive pain that comes from the internal organs. Symptoms include aches, cramps and diffuse pain. Treatment includes analgesics such as narcotics or NSAIDs and pain modifiers such as tricyclic antidepressants or anticonvulsants.

The report 'Visceral Pain - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Visceral Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews of key players involved in therapeutic development for Visceral Pain and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase I, IND/CTA Filed and Preclinical stages are 1, 1 and 9 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.

Key Topics Covered:

  1. Introduction
  2. Visceral Pain Overview
  3. Therapeutics Development
  4. Pipeline Products for Visceral Pain - Overview
  5. Pipeline Products for Visceral Pain - Comparative Analysis
  6. Visceral Pain - Therapeutics under Development by Companies
  7. Visceral Pain - Therapeutics under Investigation by Universities/Institutes
  8. Visceral Pain Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Visceral Pain - Products under Development by Companies
  13. Visceral Pain - Products under Investigation by Universities/Institutes
  14. Visceral Pain - Companies Involved in Therapeutics Development
  • Addex Therapeutics Ltd
  • Astellas Pharma Inc.
  • Chromocell Corporation
  • GIcare Pharma Inc
  • Grunenthal GmbH
  • Medestea Research & Production S.p.A.
  • Neurim Pharmaceuticals Ltd
  • Pfizer Inc.

For more information about this report visit http://www.researchandmarkets.com/research/ncrgcz/visceral_pain

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Analgesics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Analgesics